Nuveen Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$12.5M Buy
1,683,208
+361,086
+27% +$2.67M ﹤0.01% 1479
2024
Q3
$12.4M Sell
1,322,122
-5,995
-0.5% -$56.3K ﹤0.01% 1474
2024
Q2
$10.7M Sell
1,328,117
-326,555
-20% -$2.62M ﹤0.01% 1541
2024
Q1
$24.5M Buy
1,654,672
+708,780
+75% +$10.5M 0.01% 1050
2023
Q4
$7.69M Sell
945,892
-657,585
-41% -$5.35M ﹤0.01% 1752
2023
Q3
$7.3M Sell
1,603,477
-625,804
-28% -$2.85M ﹤0.01% 1670
2023
Q2
$15.7M Buy
2,229,281
+73,739
+3% +$519K 0.01% 1230
2023
Q1
$13.2M Buy
2,155,542
+808,623
+60% +$4.94M ﹤0.01% 1304
2022
Q4
$8.61M Sell
1,346,919
-391,466
-23% -$2.5M ﹤0.01% 1594
2022
Q3
$16.7M Sell
1,738,385
-60,164
-3% -$576K 0.01% 1141
2022
Q2
$19.9M Buy
1,798,549
+1,332,772
+286% +$14.7M 0.01% 1058
2022
Q1
$6.99M Sell
465,777
-211,430
-31% -$3.17M ﹤0.01% 1874
2021
Q4
$12.9M Buy
677,207
+61,929
+10% +$1.18M ﹤0.01% 1534
2021
Q3
$15.2M Sell
615,278
-10,179
-2% -$251K ﹤0.01% 1472
2021
Q2
$16.3M Buy
625,457
+10,399
+2% +$271K ﹤0.01% 1529
2021
Q1
$19.5M Sell
615,058
-46,304
-7% -$1.47M 0.01% 1343
2020
Q4
$30.7M Buy
661,362
+88,363
+15% +$4.1M 0.01% 966
2020
Q3
$18.9M Buy
572,999
+18,327
+3% +$603K 0.01% 1098
2020
Q2
$15.2M Sell
554,672
-235,831
-30% -$6.47M 0.01% 1214
2020
Q1
$23.7M Buy
790,503
+143,313
+22% +$4.29M 0.01% 811
2019
Q4
$17.9M Sell
647,190
-105,749
-14% -$2.93M 0.01% 1238
2019
Q3
$13.7M Buy
752,939
+37,031
+5% +$674K 0.01% 1366
2019
Q2
$17.6M Buy
715,908
+680,922
+1,946% +$16.7M 0.01% 1235
2019
Q1
$333K Buy
+34,986
New +$333K ﹤0.01% 912
2016
Q1
Sell
-141,357
Closed -$1.09K 1398
2015
Q4
$1.09K Sell
141,357
-6,206
-4% -$48 0.01% 1015
2015
Q3
$850 Buy
+147,563
New +$850 ﹤0.01% 1111